Position in ENGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
197,678
first reported quarter
Ownership
0.295%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARISTEIA CAPITAL, L.L.C. holds $20,645,173 across 15 Biotechnology names. ENGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
37,250 | $11,774,352 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
64,475 | $7,548,088 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
53,650 | $933,510 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
15,708 | $335,679 | |
| 5 | OABI |
OmniAb, Inc.
|
679,919 | $53,544 | |
| 6 | OSRH |
OSR Health, Inc.
|
73,341 | $0 | |
| 7 | MLEC |
Moolec Science SA
|
330,014 | $0 | |
| 8 | ASBP |
Aspire Biopharma Holdings, Inc.
|
681,516 | $0 |
All Filings in ENGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 ENGNW | — | 197,678 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||